Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of NHS policies on private access for patients with Postural Orthostatic Tachycardia Syndrome seeking faster access to specialist care.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.
Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.
By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.
Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.
The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.
Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the adequacy of NHS referral pathways for patients with Postural Orthostatic Tachycardia Syndrome, including the coordination of care between cardiology and neurology services.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.
Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.
By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.
Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.
The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.
Asked by: Stuart Andrew (Conservative - Daventry)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase access to specialist care for patients with Postural Orthostatic Tachycardia Syndrome, including reducing waiting times to see clinicians with relevant expertise.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Postural orthostatic tachycardia syndrome (PoTS) is diagnosed by a combination of general practitioners (GPs) and specialist clinicians. GPs can diagnose PoTS in many cases but, if they are unsure of symptoms or if symptoms are complex, they will refer patients to specialists for diagnosis, or where patients do not respond to initial treatment, patients may be referred to specialised cardiology or neurology services. The Royal College of General Practitioners’ Syncope Toolkit provides information to GPs, including the use of the active stand test, to rule out other conditions and potentially diagnose PoTS more quickly. Management of PoTS typically involves lifestyle changes and medications to help control symptoms, and can involve support from a multidisciplinary team.
Where patients are referred to secondary care for diagnosis, we are investing in additional capacity to deliver appointments to help bring waiting lists and times down. The Elective Reform Plan, published in January 2025, sets out the specific productivity and reform efforts needed to return to the constitutional standard, that 92% of patients to wait no longer than 18 weeks from referral to treatment, by March 2029.
By expanding community-based services for routine monitoring and follow up, employing artificial intelligence for productivity, and investing in digital tools and data, as outlined in the 10-Year Health Plan, we can ensure that consultants’ time is reserved for complex cases of PoTS, including specialist diagnostic assessments.
Integrated care boards (ICBs), with oversight from NHS England, have a statutory responsibility to commission services which meet the needs of their local populations, including for those with PoTS. It is the responsibility of ICBs to work with clinicians, service users, and patient groups to develop services and care pathways that meet the needs of patients with PoTS. While the Department recognises the significant challenges of PoTS diagnoses, responsibility for specific clinical pathways and specialist training rests with local National Health Service bodies.
The Department has made no assessment of the impact of NHS policies on private access for patients with PoTS seeking faster access to specialist care.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the financial impact of brain tumours on people with brain tumours.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government recognises the importance of sufficient support for cancer patients, including those with brain tumours. NHS England has committed to ensuring that every person diagnosed with cancer has access to personalised care. This includes needs assessments, a care plan, and health and wellbeing information and support. Through the provision of information, personalised care empowers people to manage their care and the impact of their cancer. This approach ensures that each person’s care is planned holistically, covering mental and physical health, as well as any practical or financial concerns.
The National Health Service in England runs schemes to provide financial assistance for travel to a hospital, or other NHS premises, for specialist NHS treatment or diagnostics tests, when referred by a doctor or other primary healthcare professional. This includes the NHS Healthcare Travel Costs Scheme (HTCS), which provides financial assistance to patients who do not have a medical need for transport, but who require assistance with the costs of travelling to receive certain NHS services. Patients who do not qualify for the HTCS and who are on a low income may be able to claim the costs from the Department for Work and Pensions through Universal Credit or Personal Independence Payment. NHS England and the integrated care boards are responsible for commissioning and ensuring the healthcare needs of local communities in England are met, including to those on low incomes to access cancer treatments and appropriate care.
The National Cancer Plan will be published in the new year. It will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and aftercare. It will seek to improve every aspect of cancer care to improve the experience and outcomes for people with cancer, including those with brain tumours.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to support people with brain tumours.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government recognises the importance of sufficient support for cancer patients, including those with brain tumours. NHS England has committed to ensuring that every person diagnosed with cancer has access to personalised care. This includes needs assessments, a care plan, and health and wellbeing information and support. Through the provision of information, personalised care empowers people to manage their care and the impact of their cancer. This approach ensures that each person’s care is planned holistically, covering mental and physical health, as well as any practical or financial concerns.
The National Health Service in England runs schemes to provide financial assistance for travel to a hospital, or other NHS premises, for specialist NHS treatment or diagnostics tests, when referred by a doctor or other primary healthcare professional. This includes the NHS Healthcare Travel Costs Scheme (HTCS), which provides financial assistance to patients who do not have a medical need for transport, but who require assistance with the costs of travelling to receive certain NHS services. Patients who do not qualify for the HTCS and who are on a low income may be able to claim the costs from the Department for Work and Pensions through Universal Credit or Personal Independence Payment. NHS England and the integrated care boards are responsible for commissioning and ensuring the healthcare needs of local communities in England are met, including to those on low incomes to access cancer treatments and appropriate care.
The National Cancer Plan will be published in the new year. It will have patients at its heart and will cover the entirety of the cancer pathway, from referral and diagnosis to treatment and aftercare. It will seek to improve every aspect of cancer care to improve the experience and outcomes for people with cancer, including those with brain tumours.
Asked by: Danny Beales (Labour - Uxbridge and South Ruislip)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of implementing the recommendations of the report by the Association of Optometrists entitled Key Interventions to Transform Eye Care and Eye Health, published in October 2024, relating to a national-roll out of (a) Community Urgent Eye Service and Minor Eye Conditions Service, (b) the Integrated Glaucoma Pathway, and (c) the Integrated Cataract Pathway for pre and post assessments on costs to the NHS.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
Integrated care boards (ICBs) are responsible for assessing the health needs of their local population and for commissioning primary and secondary eye care services to meet them. This can include the commissioning of enhanced eye care services from high street optical practices.
NHS England accelerator pilots have demonstrated that improved IT connectivity and a single point of access can significantly speed up eye care referrals and support more patients to be managed in the community, in line with the ambitions in the 10-Year Health Plan.
Asked by: Andrew Snowden (Conservative - Fylde)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of Resident Doctor strikes on the delivery of healthcare services in Lancashire.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department has not made a formal assessment of the potential impact of resident doctor strikes on the delivery of healthcare services in Lancashire specifically.
The National Health Service makes every effort through rigorous contingency planning to minimise disruption as a result of industrial action and to mitigate its impact on patients and the public. During the industrial action by resident doctors from 14 to 19 November 2025, data published by NHS England showed that the NHS met its ambitious goal to maintain 95% of planned care, surpassing the 93% protected during action in July, while still maintaining critical services, including maternity services and urgent cancer care. All hospitals are asked to do a pre-assessment ahead of strike action.
To minimise the potential impact of the next round of resident doctor strike action, planned for 17 to 22 December, NHS England wrote to all trusts on 15 December asking them to prepare for planned industrial action. This includes conducting risk assessments and collecting data to estimate the impact on elective care. This letter is available at the following link:
Asked by: Darren Paffey (Labour - Southampton Itchen)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact on children and families of local pauses to neurodevelopmental assessments under the NHS Right to Choose pathway; and what steps his Department is taking to ensure that interim support is available to families whose referrals have been affected.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has recognised that, nationally, demand for assessments for neurodevelopmental conditions such as autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and it recognises the need for early intervention and support.
It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including access to neurodevelopmental assessments.
Through the medium-term planning framework, published 24 October, NHS England has set clear expectations for local ICBs and trusts to improve access, experience, and outcomes for autism and ADHD services over the next three years, focusing on improving quality and productivity.
Patients’ right to choose is set out in legislation. Patients being referred to a mental health professional, including for neurodevelopmental assessments, have the right to be treated by any clinically appropriate provider who holds a contract for the provision of NHS services.
ICBs are responsible for ensuring that their processes comply with the legal right to choose. This includes any qualifying contract requirements and clinical appropriateness or eligibility criteria. ICBs also have a duty to publicise and promote choice and can provide local referral guidance to support referrers and ensure that referrals into any NHS funded service are appropriate.
There has been no change to the existing legal right patients have to choose the provider and team who will provide their elective care in certain cases. These rights extend to any provider in England who holds a contract with an ICB, or NHS England, for the service/s the patient requires, as per the NHS Choice Framework. This includes independent sector providers who deliver NHS funded care. Neurodivergent services are already in scope of this legislation.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of prolonged waiting times for ADHD assessment on children’s (a) wellbeing and (b) educational outcomes in (i) Surrey and (ii) the Surrey Heath constituency.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government has recognised that, nationally, demand for assessments for autism and attention deficit hyperactivity disorder (ADHD) has grown significantly in recent years and that people are experiencing severe delays for accessing such assessments. The Government’s 10-Year Health Plan will make the National Health Service fit for the future and recognises the need for early intervention and support. It is the responsibility of integrated care boards (ICBs) to make available appropriate provision to meet the health and care needs of their local population, including provision of autism and ADHD services, in line with relevant National Institute for Health and Care Excellence (NICE) guidelines.
The NICE guidance for the diagnosis of autism recommends that the length between referral and first appointment should be no more than 13 weeks. We know that this is not happening routinely across the country. In respect of ADHD, the NICE guideline does not recommend a maximum waiting time for people to receive an assessment for ADHD or a diagnosis, however it sets out best practice on providing a diagnosis.
Through the NHS Medium-term planning framework, published 24 October, NHS England has set clear expectations for local ICBs and trusts to improve access, experience, and outcomes for autism and ADHD services over the next three years, focusing on improving quality and productivity.
My Rt Hon. Friend, the Secretary of State for Health and Social Care, announced on 4 December the launch of an Independent Review into Prevalence and Support for Mental Health Conditions, ADHD and Autism. This independent review will inform our approach to enabling people with ADHD and autistic people to have the right support in place to enable them to live well in their communities.
Asked by: Matt Vickers (Conservative - Stockton West)
Question to the Ministry of Defence:
To ask the Secretary of State for Defence, what steps his Department is taking to expand mental health support services for (a) serving personnel and (b) veterans.
Answered by Louise Sandher-Jones - Parliamentary Under-Secretary (Ministry of Defence)
All Service personnel have access to mental health support throughout their career, including medical and non-medical services. This includes, but is not limited to, preventative support such as wellbeing services, digital content, access to interventional support, and appointments with clinical staff.
For Armed Forces personnel requiring dedicated mental healthcare, the Defence Medical Services (DMS) provides a responsive, flexible, accessible, and comprehensive treatment service.
DMS has established Defence Mental Health Networks (DMHNs) across the UK to improve access to mental health services for Service personnel. These specialist community mental health services provide enhanced access to expert assessment and treatment for service personnel experiencing mental health disorders. By introducing new single points of access, enabling the sharing of specialist skills across network locations and consolidating clinical and governance processes, DMHNs are reducing wait times to enhanced assessments and core treatment therapies.
DMS has further introduced standardised training for primary care clinicians to ensure that service personnel can access initial mental healthcare at any Defence medical centre and to strengthen the initial management of mental health disorders within primary care settings.
Where personnel leaving the Armed Forces have an enduring need for mental healthcare, DMS works in partnership with the NHS to ensure continuation of care. Personnel who have been assessed and diagnosed with a mental health need are able to access Departments of Community Mental Health (DCMH) for up to six months after discharge to provide continuity of care during the transition period until appropriate handover to other services can be completed as required.
In some circumstances a DCMH Mental Health Social Worker will undertake a full assessment of transition needs, including onward referral to NHS and third sector services for continued mental healthcare.
Throughout the UK, the MOD Veterans’ Welfare Service (VWS) provides advice and support to veterans, anyone supporting a veteran, their families and dependants. The VWS works with the Royal Navy, British Army and Royal Air Force, local authorities, voluntary organisations and service charities and will routinely assign a case manager and assist with engagement with other services where needed. In England, Op COURAGE and Op RESTORE provide a broad range of specialist mental health, physical and wellbeing care services to veterans, with similar services available in Scotland, Wales and Northern Ireland.
The VWS and Defence Transition Service deliver additional support to service leavers and their families who are most likely to face challenges as they leave the Armed Forces, including facilitating access to NHS services.
Support will also be delivered through the VALOUR programme will make it easier for veterans across the UK to access the care and support they deserve. It will connect services to help ensure veterans receive the right support, in the right place, at the right time.
One of the key component parts of VALOUR is a new network of VALOUR Recognised Centres. These centres will be located across the UK and welcome veterans and the wider Armed Forces community to provide support and guidance in key areas, including health, housing and employment. Over £27 million will be available for funding to support this initiative and the first round of funding opened to applications on 10 November 2025 and closes on 14 January 2026.
The through life mental health support now provided to Service personnel will have a positive impact on the veterans of the future; we are ensuring that Armed Forces personnel have the psychological resilience training they need to recognise mental ill-health in themselves and those around them and know how to manage it.